Press release
Cystic Fibrosis Drug Market Expected to Grow at 24.5% CAGR, Fueled by Technological Advancements and New Therapeutics
The Cystic Fibrosis Drug Market size worldwide was USD 8.85 billion in 2021 and is projected to grow at a revenue CAGR of 24.5% during the forecast period. The market is primarily driven by advancements in therapeutic technologies and treatments for the disease.One of the significant factors contributing to the growth of the market is the increasing demand for bronchodilator drugs. Cystic fibrosis damages the cells responsible for producing mucus, perspiration, and digestive fluids, and as a result, 80% of patients with cystic fibrosis are prescribed inhaled bronchodilators to widen the airways and alleviate symptoms, driving market revenue growth. These drugs are often used to treat chronic respiratory conditions such as asthma and Chronic Obstructive Pulmonary Disease (COPD), where airways become narrowed and inflamed.
Get Free Sample PDF (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/download-free-sample/661
Key players in the Cystic Fibrosis Drug Market -
• F. Hoffmann-La Roche Ltd
• Novartis AG
• Gilead Sciences, Inc.
• Vertex Pharmaceuticals Incorporated
• AbbVie Inc.
• Teva Pharmaceutical Industries Ltd
• Pharmaxis Ltd
• Mylan N.V
• Genentech, Inc.
• AstraZeneca
According to the World Health Organization (WHO), developed countries typically identify around 50% of children with cystic fibrosis within the first year of life based on family history or clinical diagnosis. Cystic fibrosis is a genetic disorder that affects several organs, including the lungs, pancreas, liver, kidneys, and gut, causing breathing difficulties and producing thick, sticky secretions that can be fatal to organs. This condition can also block pancreatic enzyme functions, leading to additional health problems. For example, research indicates that cystic fibrosis affects approximately 40,000 children and adults in the United States annually.
Segments Covered in the Report -
The global market for drugs used in treating cystic fibrosis can be segmented by drug class, route of administration, and distribution channels.
In terms of drug class outlook, the market can be divided into five categories: Cystic Fibrosis Drug Transmembrane Conductance Regulator (CFTR), Bronchodilators, Mucolytic, Pancreatic Enzyme Supplement, and Others. CFTR drugs, which address the root cause of cystic fibrosis, account for a significant share of the market. Bronchodilators, which are used to widen the airways and relieve symptoms, are also in high demand due to their effectiveness in managing respiratory symptoms. Mucolytics and pancreatic enzyme supplements are used to address respiratory and digestive symptoms, respectively. Other drugs include antibiotics, anti-inflammatory drugs, and drugs for treating non-respiratory symptoms.
By route of administration outlook, the market is segmented into two categories: oral and parenteral. Oral medications are the most common form of treatment and are preferred due to their convenience and ease of use. Parenteral medications, which are administered through injections or infusion, are typically used for severe cases or when oral medication is not effective.
The market for cystic fibrosis drugs is also segmented by distribution channels, including retail pharmacies and drug stores, online pharmacies, and hospital pharmacies. Retail pharmacies and drug stores are the most commonly used distribution channels for cystic fibrosis drugs, as they are easily accessible and convenient for patients. Online pharmacies have also gained popularity in recent years due to the convenience of ordering medications from home. Hospital pharmacies are typically used for severe cases or for inpatient treatment.
Access Full Report Description with Research Methodology and Table of Contents @ https://www.reportsanddata.com/report-detail/cystic-fibrosis-drugs-market
Strategic development:
A strategic research cooperation and licensing agreement was announced by Moderna, Inc. and Vertex Pharmaceuticals Incorporated on September 16, 2020. The agreement aims to develop lipid nanoparticles (LNP) and mRNAs for delivering gene-editing treatments to treat cystic fibrosis (CF). The focus of the three-year research cooperation is to discover and optimize novel LNPs and mRNAs that can effectively deliver gene-editing therapies to lung cells, enabling the production of functional cystic fibrosis transmembrane conductance regulator (CFTR) protein.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/661
Read More About: -
Biopharmaceuticals Manufacturing Consumables Testing Market - https://www.reportsanddata.com/report-detail/biopharmaceuticals-manufacturing-consumables-testing-market
Burn Care Centers Market - https://www.reportsanddata.com/report-detail/burn-care-centers-market
Cath Labs Market - https://www.reportsanddata.com/report-detail/cath-labs-market
Corneal Topographers Market - https://www.reportsanddata.com/report-detail/corneal-topographers-market
Empty Intravenous (IV) Bags Market - https://www.reportsanddata.com/report-detail/empty-intravenous-bags-market
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Reports and Data | Web: www.reportsanddata.com
Check our upcoming research reports @ https://www.reportsanddata.com/upcoming-reports
Visit our blog for more industry updates @ https://www.reportsanddata.com/blogs
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cystic Fibrosis Drug Market Expected to Grow at 24.5% CAGR, Fueled by Technological Advancements and New Therapeutics here
News-ID: 3040093 • Views: …
More Releases from Reports And Data

Global Automotive Variable Geometry Turbocharger Market Insight, Growth, Industr …
The automotive variable geometry turbocharger (VGT) market is an important segment within the automotive turbocharger industry, focused on advanced turbocharging technology that adjusts turbine geometry to optimize exhaust flow and boost pressure. VGTs enhance engine performance, improve fuel efficiency, and reduce emissions, making them essential in modern internal combustion engines-particularly in downsized gasoline and diesel engines. This technology supports automakers' efforts to meet stringent fuel economy and emission regulations while…

Global Automotive Vacuum Pump Market Size, Growth, Industry Trends | Reports and …
The automotive vacuum pump market is a significant segment within the automotive components industry, focusing on pumps that generate vacuum pressure essential for various vehicle functions such as brake boosters, engine control, HVAC systems, and emission control. These pumps improve vehicle safety, performance, and efficiency and are critical in modern internal combustion engine (ICE) vehicles as well as in hybrid and electric vehicles (EVs), especially as engine downsizing and electrification…

Global Automotive Tie Rod Assembly Market Set for Rapid Growth - Reports and Dat …
The automotive tie rod assembly market is a key segment within the automotive steering system components industry, focusing on the manufacture and supply of tie rod assemblies that are essential for precise steering control, vehicle stability, and safety. Tie rod assemblies connect the steering gear to the wheels and play a crucial role in translating driver steering input into wheel movement. These assemblies are widely used across passenger cars, light…

Global Automotive Transmission Valve Spool Market Insight, Growth, Industry Tren …
The automotive transmission valve spool market is a vital segment within the automotive transmission components industry, focusing on manufacturing and supplying valve spools that control hydraulic fluid flow inside transmission systems. These valve spools are critical for enabling smooth gear shifts, optimizing transmission performance, and enhancing overall vehicle efficiency and reliability. They are widely used across automatic and advanced transmission systems in passenger cars, commercial vehicles, and increasingly in hybrid…
More Releases for Cystic
Cystic Fibrosis Market Report-Growth with Industry Study, Detailed Analysis | Cy …
The research study contains an in detail descriptive overview and analysis of the Cystic Fibrosis Market, a summary of the market shares constituted by each component, the annual growth of each sector, and the revenue potential of the section. In addition, Cystic Fibrosis Market production and consumption data are used to determine the geographical features.
Get FREE PDF sample of the Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=3639856
Top Company Profile Analysis in this Report-
Cystic Fibrosis…
The Cystic Fibrosis Market to Witness Robust Growth Due to Increasing Cases of C …
Cystic fibrosis is a rare, progressive, life-threatening disease results in the formation of thick mucus that builds up in the lungs, digestive tract, and other parts of the body. If left untreated, it leads to severe digestive and respiratory problems as well as other complications such as infections and diabetes. According to the Cystic Fibrosis Foundation, more than 70,000 people are living with cystic fibrosis around the world. As the…
Cystic Fibrosis Market Opportunity Analysis, 2018-2026
Cystic fibrosis (CF) is a genetic disorder that usually affects the lungs and may also affect the pancreas, kidneys, liver, and intestine. Long-term repercussions including difficulty in breathing and coughing as a result of recurrent lung infections can be seen in CF. Some of the other signs and symptoms include sinus infections, poor growth, infertility in males, fatty stool, and guild of the fingers and toes. Different individuals may have…
Cystic Fibrosis Therapeutics Market Research Reports 2017
This report studies sales (consumption) of Cystic Fibrosis Therapeutics in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Vertex Pharmaceuticals , F. Hoffmann-La Roche , AbbVie , Gilead Science , Novartis , AstraZeneca , Bayer , Celtaxsys , Pharmaxis , ProQR Therapeutics , PTC Therapeutics…
Cystic Fibrosis - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Cystic Fibrosis - Heat Map and Analysis to its growing collection of premium market research reports.
Cystic fibrosis (CF) is a progressive genetic condition and is the result of a patient inheriting a faulty cystic fibroses transmembrane conductance regulator (CFTR) gene from both parents. The defective CFTR genes produce faulty CFTR proteins on the body’s epithelial cells, and result in…
Cystic Fibrosis - Heat Map And Analysis
MarketResearchReports.Biz is providing you Latest Market Research report of "Cystic Fibrosis - Heat Map And Analysis".
Cystic fibrosis (CF) is a progressive genetic condition and is the result of a patient inheriting a faulty cystic fibroses transmembrane conductance regulator (CFTR) gene from both parents. The defective CFTR genes produce faulty CFTR proteins on the body?s epithelial cells, and result in the buildup of a thick and sticky mucus in the lungs…